Treatment failure following complete cytoreductive surgery and perioperative intraperitoneal chemotherapy for peritoneal dissemination from colorectal or appendiceal mucinous neoplasms

Journal of Surgical Oncology

Volumn 98, Issue 4, 2008, Pages 295-299

  Bijelic, Lana ^a   Yan, Tristan D ^b   Sugarbaker, Paul H ^a,c  

^a WASHINGTON CANCER INSTITUTE   (United States)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

^c NONE   (United States)

Author keywords

Appendiceal neoplasms; Colorectal cancer; Cytoreductive surgery; Intraperitoneal chemotherapy; Pseudomyxoma peritonei; Recurrence; Survival

Indexed keywords

FLUOROURACIL; MITOMYCIN C;

APPENDIX TUMOR; CANCER CHEMOTHERAPY; CANCER PATIENT; CANCER RECURRENCE; CANCER SURGERY; CANCER SURVIVAL; CARCINOMATOUS PERITONITIS; COLORECTAL CANCER; CONFERENCE PAPER; CYTOREDUCTIVE SURGERY; DATA BASE; DRUG EFFICACY; HUMAN; PERIOPERATIVE PERIOD; PERITONEUM METASTASIS; PRIORITY JOURNAL; PROSPECTIVE STUDY; TREATMENT FAILURE;

EID: 50849115518     PISSN: 00224790     EISSN: 10969098     Source Type: Journal    
DOI: 10.1002/jso.21084     Document Type: Conference Paper

References (12)

1. Sugarbaker PH: New standard of care for appendiceal epithelial neoplasms and pseudomyxoma peritonei syndrome? Lancet Oncol 2006;7:69-76.
2. Yan TD, Welch L, Black D, et al.: A systematic review on the efficacy of cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for diffuse malignant peritoneal mesothelioma. Ann Oncol 2007;18:827-834.
3. Glehen O, Kwiatkowski F, Sugarbaker PH, et al.: Cytoreductive surgery with perioperative intraperitoneal chemotherapy for the management of peritoneal carcinomatosis from colorectal cancer: a multi-institutional study. J Clin Oncol 2004;22:3284-3292.
4. Verwaal VJ, van Ruth S, de Bree E, et al.: Randomized trial of cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy and palliative surgery in patients with peritoneal carcinomatosis of colorectal origin. J Clin Oncol 2003;21:3737-3743.
5. Sugarbaker PH: Peritonectomy procedures. Ann Surg 1995;221:29-42.
6. Yan TD, Black D, Savady R, et al.: A systematic review on the efficacy of cytoreductive surgery and perioperative intraperitoneal chemotherapy for pseudomyxoma peritonei. Ann Surg Oncol 2007;14:484-492.
7. Gonzalez-Moreno S: Peritoneal surface oncology: A progress report. Eur J Sur Oncol 2006;32:593-596.
8. Verwaal VJ, Boot H, Aleman BMP, et al.: Recurrences after peritoneal carcinomatosis of colorectal origin treated by cytoreduction and hyperthermic intraperitoneal chemotherapy: Location, treatment and outcome. Ann Surg Oncol 2003;11:375-379.
9. Elias D, Sideris L, Pocard M, et al.: Efficacy of intraperitoneal chemohyperthermia with oxaliplatin in colorectal peritoneal carcinomatosis. Preliminary results in 24 patients. Ann Oncol 2004;15:781-785.
10. Armstrong DK, Bundy B, Wenzel L, et al.: Intraperitoneal cisplatin and paclitaxel in ovarian cancer. N Engl J Med 2006;354:34-43.
11. Markman M, Bundy B, Alberts D, et al.: Phase III trial of standard-dose intravenous cisplatin plus paclitaxel versus moderately high-dose carboplatin followed by intravenous paclitaxel and intraperitoneal cisplatin in small-volume stage III ovarian carcinoma: an intergroup study of the Gynecologic Oncology Group, Southwestern Oncology Group and Eastern Cooperative Oncology Group. J Clin Oncol 2001;19:1001-1007.
12. Alberts DS, Liu PY, Hannigan EV, et al.: Intraperitoneal cisplatin plus intravenous cyclophosphamide versus intravenous cisplatin plus intravenous cyclophosphamide for stage III ovarian cancer. N Engl J Med 1996;335:1950-1955.